|
|
|
|
|
27.10.25 - 06:15
|
Research: M Stanley's APxJ Focus List (Table) (AAStocks)
|
|
|
Hong Kong-listed Stocks:TENCENT (00700.HK)WYNN MACAU (01128.HK)XPENG-W (09868.HK)Other Regional Stocks:India’s Bajaj Finance (BJFN.NS)Delta Electronics (2308.TW)Australia’s Gemlife Communities (GLF.AX)South Korea’s Hana Financial Group (086790.KS)South Korea’s Hanwha Aerospace (012450.KS)India’s ICI......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.10.25 - 06:18
|
DBS China CEO on Business Strategy (Bloomberg)
|
|
|
Ginger Cheng, China CEO at DBS, discusses the bank's business strategy in the country. She speaks with Stephen Engle from the sidelines of the Bund Summit in Shanghai. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
22.10.25 - 14:03
|
CytoMed Therapeutics′ Chairman Increases Effective Holdings to 21.95% (GlobeNewswire EN)
|
|
|
SINGAPORE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood and solid tumours, today announced that its Executive Chairman and substantial shareholder, Mr Peter Choo has increased his shareholding in the Company through recent open-market purchases of 105,824 shares. This is on top of 187,500 shares which he holds personally, bringing his personal stake in CytoMed to 2.50% as of today. In addition, our Chairman is also a 55% shareholder of Glorious Finance Limited, and the sole shareholder of EP Capital Inc, representing 2,282,422 shares, or 19.45% of the Company. In aggregate, he owns 2,388,246 shares representing 21.95% of the Company's total outstanding shares....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alle News zu Singapur 447.9075 +0.63% (STI Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
